SEC Form 4 · accession 0001140361-15-029489
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jorge Saucedo
Director
Period of report
Jul 30, 2015
Accepted (ET)
Aug 3, 2015 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 30, 2015 | M | 10,000 | $9.41 | A | 29,320 | D | |
| Common Stock | Jul 30, 2015 | M | 10,000 | $6.36 | A | 39,320 | D | |
| Common StockF1 | Jul 30, 2015 | S | 6,039 | $37.36 | D | 33,281 | D | |
| Common StockF2 | Jul 31, 2015 | S | 3,961 | $37.30 | D | 29,320 | D | |
| Common Stock | holding | — | — | — | 19,320 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $9.41 | Jul 30, 2015 | M | 10,000 | D | — | Apr 24, 2017 | Common Stock | 10,000 | 0 | D |
| Stock Option (Right to Buy)F3 | $6.36 | Jul 30, 2015 | M | 10,000 | D | — | Apr 22, 2018 | Common Stock | 10,000 | 0 | D |
| Stock Option (Right to Buy)F3 | $6.39 | holding | — | — | — | — | Apr 21, 2019 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F3 | $9.61 | holding | — | — | — | — | Apr 22, 2020 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F3 | $11.72 | holding | — | — | — | — | Apr 22, 2021 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy)F3 | $11.63 | holding | — | — | — | — | May 4, 2022 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The price in column 4 is a weighted average price. The price actually received for the stock ranged from $37.25 to $37.50 per share. Dr. Saucedo has provided to the Company and, upon request, will provide any security holder of the Company, or the SEC staff, information regarding the number of shares sold at each price within that range.
- F2The price in column 4 is a weighted average price. The price actually received for the stock ranged from $37.25 to $37.32 per share. Dr. Saucedo has provided to the Company and, upon request, will provide any security holder of the Company, or the SEC staff, information regarding the number of shares sold at each price within that range.
- F3100% fully vested.